BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gerber LH, Weinstein AA, Mehta R, Younossi ZM. Importance of fatigue and its measurement in chronic liver disease. World J Gastroenterol 2019; 25(28): 3669-3683 [PMID: 31391765 DOI: 10.3748/wjg.v25.i28.3669]
URL: https://www.wjgnet.com/1007-9327/full/v25/i28/3669.htm
Number Citing Articles
1
Erica Nicola Lynch, Claudia Campani, Tommaso Innocenti, Gabriele Dragoni, Maria Rosa Biagini, Paolo Forte, Andrea Galli. Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectivesWorld Journal of Hepatology 2022; 14(6): 1111-1119 doi: 10.4254/wjh.v14.i6.1111
2
Oh Young Kwon, Seung Up Kim, Sang Hoon Ahn, Yeonsoo Jang. Self-Management and Associated Factors among Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional StudyInternational Journal of Environmental Research and Public Health 2022; 20(1): 667 doi: 10.3390/ijerph20010667
3
Kristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Charlotte Wilhelmina Wernberg, Lea Ladegaard Grønkjær, Peter Lykke Eriksen, Malene Flensborg Damholdt, Rajeshwar Prosad Mookerjee, Hendrik Vilstrup, Mette Munk Lauridsen, Karen Louise Thomsen. Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease—Current Knowledge, Mechanisms and PerspectivesJournal of Clinical Medicine 2021; 10(4): 673 doi: 10.3390/jcm10040673
4
Dana Shamshtein, Timur Liwinski. Pathogenesis and management of fatigue in primary biliary cholangitisFatigue: Biomedicine, Health & Behavior 2022; 10(1): 1 doi: 10.1080/21641846.2022.2034473
5
Zobair M. Younossi, James M. Paik, Pegah Golabi, Youssef Younossi, Linda Henry, Fatema Nader. The impact of fatigue on mortality of patients with non‐alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005–2010 and 2017–2018Liver International 2022; 42(12): 2646 doi: 10.1111/liv.15437
6
Sue Shea, Christos Lionis, Lou Atkinson, Chris Kite, Lukasz Lagojda, Surinderjeet S. Chaggar, Ioannis Kyrou, Harpal S. Randeva. Support Needs and Coping Strategies in Non-Alcoholic Fatty Liver Disease (NAFLD): A Multidisciplinary Approach to Potential Unmet Challenges beyond Pharmacological TreatmentLivers 2022; 3(1): 1 doi: 10.3390/livers3010001
7
Krishnagopal Bhandari, Dharmesh Kapoor. Fatigue in CirrhosisJournal of Clinical and Experimental Hepatology 2022; 12(2): 617 doi: 10.1016/j.jceh.2021.08.028
8
Lei Shen, Soon Lee, Jong Cheon Joo, Jing Yuan Tian, Ming Ge Chen, Yan Liu, Jong-In Baek, Byeong Min Jeon, Sun Chang Kim, Ki-Chan Ha, Yu-Kyung Park, Hyang-Im Baek, Soo Jung Park. Effectiveness and safety of SGL 121(ginsenoside F2-enhanced mixture) in hepatic dysfunction: A randomized, double-blind, placebo-controlled clinical trialJournal of Functional Foods 2022; 98: 105290 doi: 10.1016/j.jff.2022.105290
9
Zobair M. Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Castellanos Fernandez, Vasily A. Isakov, Ajay K. Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, George V. Papatheodoridis, Wah Kheong Chan, Khalid Alswat, Hamid S. Saeed, Ashwani K. Singal, Manuel Romero-Gomez, Stuart C. Gordon, Stuart K. Roberts, Mohamed El Kassas, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Mariam Ziayee, Brian Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) RegistryClinical Gastroenterology and Hepatology 2022; 20(10): 2296 doi: 10.1016/j.cgh.2021.11.004
10
Wagdi Almishri, Liam A. Swain, Charlotte D’Mello, Tyson S. Le, Stefan J. Urbanski, Henry H. Nguyen. ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in MiceFrontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.779119
11
Alice Freer, Felicity Williams, Simon Durman, Jennifer Hayden, Palak J Trivedi, Matthew J Armstrong. Home-based exercise in patients with refractory fatigue associated with primary biliary cholangitis: a protocol for the EXerCise Intervention in cholesTatic LivEr Disease (EXCITED) feasibility trialBMJ Open Gastroenterology 2021; 8(1): e000579 doi: 10.1136/bmjgast-2020-000579
12
Julia A. Golubeva, Anna F. Sheptulina, Adel A. Yafarova, Elvira M. Mamutova, Anton R. Kiselev, Oxana M. Drapkina. Reduced Quality of Life in Patients with Non-Alcoholic Fatty Liver Disease May Be Associated with Depression and FatigueHealthcare 2022; 10(9): 1699 doi: 10.3390/healthcare10091699
13
Shari S. Rogal, Lissi Hansen, Arpan Patel, Nneka N. Ufere, Manisha Verma, Christopher D. Woodrell, Fasiha Kanwal. AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosisHepatology 2022; 76(3): 819 doi: 10.1002/hep.32378
14
Yoshiya Tanaka, Kei Ikeda, Yuko Kaneko, Naoki Ishiguro, Tsutomu Takeuchi. Why does malaise/fatigue occur? Underlying mechanisms and potential relevance to treatments in rheumatoid arthritisExpert Review of Clinical Immunology 2024; : 1 doi: 10.1080/1744666X.2024.2306220
15
Mina Rakoski, Lissi Hansen, Manisha Verma, Christopher D. Woodrell. Evidence-Based Practice of Palliative Medicine2023; : 371 doi: 10.1016/B978-0-323-84702-5.00044-0
16
Linda Henry, James Paik, Zobair M. Younossi. Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the worldAlimentary Pharmacology & Therapeutics 2022; 56(6): 942 doi: 10.1111/apt.17158
17
Wenxin Xia, Heming Zhang, Mengxin Tao, Hao Zhou, Jiahua Ma, Tingting Li, Xiaofen Huang, Xueyan Fu. Multi-omics techniques to compare the potential of raw and processed licorice as food supplements for ameliorating chronic fatigue syndromeFood Bioscience 2023; 56: 103334 doi: 10.1016/j.fbio.2023.103334
18
Sakura Yamamura, Dan Nakano, Ryuki Hashida, Tsubasa Tsutsumi, Takumi Kawaguchi, Michiaki Okada, Hiroshi Isoda, Hirokazu Takahashi, Hiroo Matsuse, Yuichiro Eguchi, Yoshio Sumida, Atsushi Nakajima, Lynn Gerber, Zobair M Younossi, Takuji Torimura. Patient‐reported outcomes in patients with non‐alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire‐non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitisJournal of Gastroenterology and Hepatology 2021; 36(3): 629 doi: 10.1111/jgh.15172
19
Alaa M. Mostafa, Shaimaa Moustafa Hafez, Noha M. Abdullah, Yasser Fouad. Fatigue, depression, and sleep disorders are more prevalent in patients with metabolic-associated fatty liver diseasesEuropean Journal of Gastroenterology & Hepatology 2024;  doi: 10.1097/MEG.0000000000002752
20
Jing Liu, Xiying Gong, Haifeng Lv, Shiyi Liu, Yanming Jiang, Geli Zhu, Xiaojie Ma, Jie Wang, Xiaoping Ye, Yidan Gao, Jie Li, Gongying Chen, Junping Shi. Is fatigue related to the severity of liver inflammation in patients with chronic liver disease? A cross-sectional studyBMJ Open 2023; 13(4): e069028 doi: 10.1136/bmjopen-2022-069028
21
Kyohei Takano, Marisa Kaneda, Yayoi Aoki, Nina Fujita, Shigeki Chiba, Seiwa Michihara, Li-Kun Han, Ryuji Takahashi. The protective effects of Ninjin’yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouseJournal of Natural Medicines 2024;  doi: 10.1007/s11418-024-01786-2
22
Lina Wang, Jing Zhang, Yali Liu, Huixuan Zhou, Wenjing Yan, Hong Ren. The Relationship between Health-Related Fitness and Quality of Life in Nonalcoholic Fatty Liver DiseaseInternational Journal of Environmental Research and Public Health 2022; 19(21): 14215 doi: 10.3390/ijerph192114215
23
Ravi Gupta, Rohit Gupta, Niraj Kumar, Vikram Singh Rawat, Jan Ulfberg, Richard Putnam Allen. Restless legs syndrome among subjects having chronic liver disease: A systematic review and meta-analysisSleep Medicine Reviews 2021; 58: 101463 doi: 10.1016/j.smrv.2021.101463
24
Austin Henry, James M. Paik, Patrick Austin, Katherine Elizabeth Eberly, Pegah Golabi, Issah Younossi, Linda Henry, Lynn Gerber, Zobair M. Younossi. Vigorous physical activity provides protection against all‐cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD)Alimentary Pharmacology & Therapeutics 2023; 57(6): 709 doi: 10.1111/apt.17308
25
Chun-Yi Chi, Jui Wang, Szu-Ying Lee, Chia-Ter Chao, Kuan-Yu Hung, Kuo-Liong Chien. The Impact of Glucose-Lowering Strategy on the Risk of Increasing Frailty Severity among 49,519 Patients with Diabetes Mellitus: A Longitudinal Cohort StudyAging and disease 2023; 14(5): 1917 doi: 10.14336/AD.2023.0225
26
Maria Stepanova, Linda Henry, Zobair M. Younossi. Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease 2023; 27(2): 483 doi: 10.1016/j.cld.2023.01.007
27
Granata Francesca, Annamaria Nicolli, Alessia Colaiocco, Elena Di Pierro, Giovanna Graziadei. Psychological Aspect and Quality of Life in Porphyrias: A ReviewDiagnostics 2022; 12(5): 1193 doi: 10.3390/diagnostics12051193
28
Liang Tang, Sufang Kang, Wenkang Yan, Yanan Yu, Jiaxiang Li, Wanzhao Wang, Zhanke Ma, Xiushan Fan, Lijun Sun. Low intensity pulsed ultrasound reduces liver inflammation caused by fatigue exerciseThe Journal of the Acoustical Society of America 2023; 153(2): 1375 doi: 10.1121/10.0017355
29
Oliver Glass, Daniel Liu, Elizabeth Bechard, Cynthia D. Guy, Jane Pendergast, Anna Mae Diehl, Manal F. Abdelmalek. Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey‐Based StudyHepatology Communications 2022; 6(2): 334 doi: 10.1002/hep4.1808
30
Е. V. Garanina. Влияние курсового приема L-орнитин- L-аспартата на фиброз и стеатоз печени у больных ассоциированной с нарушениями метаболизма жировой болезнью печени (неалкогольной жировой болезнью печени), имеющих гипераммониемиюRussian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(4): 31 doi: 10.22416/1382-4376-2021-31-4-31-36
31
Anne-Laure Tardy, Sophie Marguet, Halley Costantino, Andrew Stewart, deMauri Mackie, Grèce Saba, Caroline Amand. Profile and quality of life of the adult population in good health according to the level of vitality: European NHWS cross sectional analysisBMC Public Health 2023; 23(1) doi: 10.1186/s12889-023-15754-0
32
E. Yu. Plotnikova, M. N. Sinkova, L. K. Isakov. Asthenia and fatigue in hyperammonemia: etiopathogenesis and methods of correctionMeditsinskiy sovet = Medical Council 2022; (21-1): 95 doi: 10.21518/2079-701X-2021-21-1-95-104
33
Tatyana Vasiliyevna Polukchi, Gulzhan Narkenovna Abuova, Yelena Alekseevna Slavko. The Neuropsychiatric Aspect of the Chronic Viral HepatitisPrague Medical Report 2023; 124(2): 94 doi: 10.14712/23362936.2023.8
34
Zhaozhou Zhang, Liqing Du, Qiuchen Ji, Hao Liu, Zhenxing Ren, Guang Ji, Zhao-Xiang Bian, Ling Zhao. The Landscape of Gut Microbiota and Its Metabolites: A Key to Understanding the Pathophysiology of Pattern in Chinese MedicineThe American Journal of Chinese Medicine 2024; 52(01): 89 doi: 10.1142/S0192415X24500046
35
Shelley E. Keating, Angelo Sabag, Kate Hallsworth, Ingrid J. Hickman, Graeme A. Macdonald, Jonathan G. Stine, Jacob George, Nathan A. Johnson. Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science AustraliaSports Medicine 2023; 53(12): 2347 doi: 10.1007/s40279-023-01918-w
36
Hyejin Jeon, Kippeum Lee, Yong-Tae Kim, Joo-Yun Kim, Jae-Jung Shim, Jae-Hwan Lee. Effect of HY7602 Fermented Deer Antler on Physical Fatigue and Antioxidant Activity in MiceInternational Journal of Molecular Sciences 2024; 25(6): 3318 doi: 10.3390/ijms25063318
37
Pavapol Sirisunhirun, Wimolrak Bandidniyamanon, Yonworanat Jrerattakon, Kobkun Muangsomboon, Pornpoj Pramyothin, Supot Nimanong, Tawesak Tanwandee, Phunchai Charatcharoenwitthaya, Siwaporn Chainuvati, Watcharasak Chotiyaputta. Effect of a 12-week home-based exercise training program on aerobic capacity, muscle mass, liver and spleen stiffness, and quality of life in cirrhotic patients: a randomized controlled clinical trialBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02147-7
38
Rasha R. El-Kady, Amani K. Ali, Lamia M. El Wakeel, Nagwa A. Sabri, May A. Shawki. Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trialTherapeutic Advances in Chronic Disease 2022; 13: 204062232210779 doi: 10.1177/20406223221077958
39
Aleksandr I. Pavlov, Aleksandr F. Ivolgin, Sergei V. Katenko, Mikhail N. Eremin, Alevtina I. Molodova, Olga B. Levchenko, Aram G. Karakozov. Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndromeTerapevticheskii arkhiv 2021; 93(8): 890 doi: 10.26442/00403660.2021.08.200974
40
Yusuf Yilmaz, Ahmet Eren Toraman, Ceyda Alp, Zehra Doğan, Caglayan Keklikkiran, Maria Stepanova, Zobair Younossi. Impairment of patient‐reported outcomes among patients with non‐alcoholic fatty liver disease: a registry‐based studyAlimentary Pharmacology & Therapeutics 2023; 57(2): 215 doi: 10.1111/apt.17301
41
Kazuki Takakura, Machi Suka, Mikio Kajihara, Shigeo Koido. Clinical features, therapeutic outcomes, and recovery period of long COVIDJournal of Medical Virology 2023; 95(1) doi: 10.1002/jmv.28316
42
Zobair M. Younossi, Maria Stepanova, Robert P. Myers, Issah Younossi, Linda Henry. The Potential Role of Fatigue in Identifying Patients With NASH and Advanced Fibrosis Who Experience Disease ProgressionClinical Gastroenterology and Hepatology 2023; 21(4): 970 doi: 10.1016/j.cgh.2022.04.023